Scientific Advisory Board
S. Vincent Rajkumar, MD IMF Board Chair
Thomas Martin, MD
UCSF, Helen Diller Family Comprehensive Cancer Center
Wee Joo Chng, MD
National University of Singapore
María-Victoria Mateos, MD, PhD University of Salamanca
Vania Hungria, MD, PhD Santa Casa de São Paulo
Joseph Mikhael, MD, MEd, FRCPC, FACP IMF Chief Medical Officer
Sigurður Yngvi Kristinsson, MD, PhD University of Iceland
Philippe Moreau, MD University Hospital of Nantes
Shaji Kumar, MD Mayo Clinic
NIkhil Munshi, MD Dana-Farber Cancer Institute
Jesús San Miguel, MD, PhD University of Navarra
Sagar Lonial, MD, FACP
Winship Cancer Institute, Emory University
Saad Zafar Usmani, MD, MBA, FACP, FASCO
Memorial Sloan Kettering Cancer Center
The IMF Support Group Team is Here
For You!
Shared Experiences Help to Better Understand the Myeloma Journey
• Support Groups empower patients & care partners with information, insight & hope
• The IMF provides educational support to a network of over 150 myeloma specific groups
150+ US Support Groups
Over 200 Support Group Visits/year
Los Angeles
Meets virtually on the 3rd Saturday of each month at 10:30AM Pacific Time
City of Hope
Meets virtually on the 3rd Wednesday of each month at 3:00PM Pacific Time
Rancho Mirage
Meets in-person on the 1st Thursday of each month at 3:00PM Pacific Time
Inland Empire
Meets hybrid on the 3rd Saturday of each month at 11:00AM Pacific Time
Sacramento
Napa Valley/Sonoma
Meets virtually on the 2nd Friday of each month at 10:00AM Pacific Time
Meets virtually on the 1st Saturday of each month at 10:00AM Pacific Time
San Diego
Meets hybrid on the 2nd Monday of each month at 6:30PM Pacific Time
San Fernando Valley
Meets virtual on the 3rd Wednesday of each month at 7:00PM Pacific Time
Orange County
Meets virtually on the 1st Thursday of each month at 6:00PM Pacific Time
San Francisco Bay Area
Meets virtually on the 3rd Saturday of each month at 10:00AM Pacific Time
San Gabriel Valley
Meets hybrid on the 1st Monday of each month at 6:30PM Pacific Time
Santa Cruz
Meets virtually on the 1st Monday of each month at 4:30PM Pacific Time
Upland
Meets hybrid on the 1st Friday of each month at 10:00AM Pacific Time
Westlake Village/ Thousand Oaks/ Ventura County
Meets virtually on the 2nd Saturday of each month at 11:00AM Pacific Time
Special Interest Groups
Special interest groups are designed as a supplemental support for specific populations of patients, in addition to their local Support Groups
MM Families
Founded in 2021
For patients & care partners with young children
Las Voces de Mieloma
Founded in 2022
For Spanish speaking patients & care partners
Living Solo & Strong
Founded in 2022
For patients without a care partner
Click here for more inf
Smolder Bolder
Founded in 2023
For smoldering myeloma patients & care partners
Veterans SIG
Founded in 2025
For those who served our country
High Risk Multiple Myeloma
Founded in 2023
For high-risk myeloma patients & care partners
Care Partners Only
Founded in 2024
For myeloma care partners only
CLINICAL TRIALS MATCHING ENGINE
Seamlessly matching patients to the latest clinical trials.
• Discover clinical trials tailored to your myeloma journey with the IMF.
• Filter by diagnosis, treatment, and location to find the best fit for you.
Clinical Trials Matching Engine Usage
WRITTEN EDUCATION
Live Patient Education
2025 Live Patient Education
Patient & Family Seminars
• Boca Raton, FL – March 14 – 15
• Philadelphia, PA – May 2 – 3
• Los Angeles, CA – August 15 – 16
• Chicago, IL – October 3 – 4
Myeloma Community Workshops
• Virtual - March 4
• San Mateo, CA - March 29
• Atlanta, GA - April 5
• Edina, MN - April 26
• Denver, CO - June 21
• Virtual – July 29
• Seattle, WA - August 9
• Waltham, MA - September 27
• Raleigh-Durham, NC - November 15
• Virtual – November 18
1. Ensure Access to Care: We advocate to ensure all myeloma patients have equitable, comprehensive, patient-centered care without insurance barriers that limit options or delay treatment initiation.
2. Eliminate Financial Barriers: We advocate for policies that allow myeloma patients access to treatments and supportive care interventions without facing financial hardships.
3. Advance Myeloma Research: We advocate for annual appropriations funding for myeloma research and the advancement of clinical trial eligibility and research protocols that ensure representation from diverse populations.
The IMF Grassroots Advocacy Program is multi-faceted and growing
• Advocacy Training & Leadership Development
• Policy and Legislative Education
• Grassroots Campaign Planning
• Health Policy Forums & Roundtables
• Advocacy Resource Development
• Storytelling and Personal Narratives
Scan for Upcoming Programs and Events!
